_1777352244987_250242181.png&w=48&q=75){kind=small}
Egyptian insulin matches imported quality
The head of the Pharmaceuticals Department confirmed that the recent controversy over the insulin shortage is fabricated, as patients are insisting on the imported branded product, despite the availability of the Egyptian alternative in large quantities for the past ten years, offering the same quality and effectiveness. He added that the insulin shortage is not genuine, and the market is filled with sufficient local stock to meet the demand, indicating that the crisis is baseless.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)